Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Spasticity in Participants With Multiple Sclerosis”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Large-scale testing (Phase 3)Ended earlyNCT04984278
What this trial is testing

Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis

Who this might be right for
Spasticity With Multiple Sclerosis
Jazz Pharmaceuticals 56
Large-scale testing (Phase 3)Ended earlyNCT04203498
What this trial is testing

Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)
Jazz Pharmaceuticals 139
Not applicableStudy completedNCT06868342
What this trial is testing

Nerve Root Block in Spasticity

Who this might be right for
SpasticitySpasticity in Participants With Multiple SclerosisSpasticity Post Stroke+1 more
Walton Centre NHS Foundation Trust 4
Testing effectiveness (Phase 2)Looking for participantsNCT06782490
What this trial is testing

Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

Who this might be right for
Multiple Sclerosis Spasticity
Celgene 200
Large-scale testing (Phase 3)Study completedNCT04657666
What this trial is testing

Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis

Who this might be right for
Spasticity in Participants With Multiple Sclerosis
Jazz Pharmaceuticals 68
Early research (Phase 1)Ended earlyNCT04990219
What this trial is testing

Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
H. Lundbeck A/S 37